Treosulfan
 |
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral, IV |
| ATC code | |
| Identifiers | |
|
|
| Synonyms | 1,2,3,4-Butanetetrol, 1,4-dimethanesulfonate, Threitol 1,4-dimethanesulfonate, Threitol 1,4-bismethanesulfonate; L-Threitol 1,4-bis(methanesulfonate); Ovastat; Threosulphan; Treosulphan; Tresulfan |
| CAS Number | |
| PubChem CID | |
| UNII | |
| ECHA InfoCard | 100.005.529 |
| Chemical and physical data | |
| Formula | C6H14O8S2 |
| Molar mass | 278.30056 g·mol−1 |
| Melting point | 101.5 to 105 °C (214.7 to 221.0 °F) |
  (what is this?)
|
|
Treosulfan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called alkylating agents. It has been used mainly as a substitute of busulfan in frail patients, as the side effects and toxicity are supposedly less severe.
This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".
...
Wikipedia